Central nervous system tumor (peds): Difference between revisions

No edit summary
No edit summary
Line 12: Line 12:
***[[Cranial nerve palsies]] (especially 6th nerve)
***[[Cranial nerve palsies]] (especially 6th nerve)
**Brainstem
**Brainstem
***CN deficits (facial weakness, abducens palsy, dysphagia), ataxia
***[[Cranial nerve palsies]] (facial weakness, abducens palsy, dysphagia), ataxia
**Supratentorial
**Supratentorial
***Headache, personality change, motor [[weakness]], [[seizure]]
***[[Headache]], personality change, motor [[weakness]], [[seizure]]
**Sellar
**Sellar
***Visual changes, hypothalamic dysfunction (DI, stunted growth, hypothyroidism)
***[[Visual disturbances|Visual changes]], hypothalamic dysfunction ([[diabetes insipidus]], stunted growth, [[hypothyroidism]])


==Differential Diagnosis==
==Differential Diagnosis==
Line 26: Line 26:
==Management==
==Management==
*[[Increased ICP]]
*[[Increased ICP]]
**Phenytoin, benzodiazepines if actively seizing
**[[Phenytoin]], [[benzodiazepines]] if actively seizing
**[[Dexamethasone]] 1mg/yr of age (max 10mg)
**[[Dexamethasone]] 1mg/yr of age (max 10mg)
***Do NOT give if CNS lymphoma is in the differential
***Do NOT give if CNS lymphoma is in the differential

Revision as of 18:37, 14 September 2019

For adult patients, see also brain tumor

Background

  • 2nd most common pediatric cancer (20%)

Clinical Features

Differential Diagnosis

Pediatric Headache

Evaluation

Management

See Also

References